Metabolic Characterization Of Non-Diabetic Severely Obese Patients Undergoing Gastric Bypass; Preoperative Classification Predicts The Effects Of Surgery On Insulin-Glucose Homeostasis
Richard A. Perugini, Stephen Quarfordt, Donald Czerniach, MItchell Cahan, John J. Kelly, Demetrius E. Litwin; Surgery, UMass Medical School, Worcester, MA
INTRODUCTION: Obesity is associated with insulin resistance (IR) and diabetes (DM). Some obese individuals, however, have normal insulin-glucose metabolism. While gastric bypass (GB) cures IR and DM, its effects on normal physiology have not been described; in addition, there are reports of postoperative pathological hypoglycemia. We studied IR and beta-cell sensitivity for patients undergoing gastric bypass. METHODS: 123 patients undergoing GB had fasting insulin and glucose levels drawn on days 0, 12, 40, 180, and 365. Twenty nine (24%) patients with DM were excluded from this analysis. Homeostasis model of assessment was used to estimate IR (HOMA-IR) and beta-cell sensitivity (HOMA-B). Patients were categorized with IR if HOMA-IR > 3.6. HOMA-B of 100 signified normal beta-cell sensitivity. Student’s t-test was used to determine whether differences were significant. RESULTS: Adipose mass, as estimated by BMI, did not correlate with IR. Forty three (35%) patients had IR. Correction of IR for this group occurred by 12 days postoperatively. Fifty one (41%) patients did not have IR, with normal HOMA-IR and HOMA-B preoperatively. They demonstrated an increase of beta-cell sensitivity by 12 days postoperatively, which corrected by six-months. Major alterations in HOMA-IR or HOMA-B occurred by 12 days, after which the IR and non-IR groups mirrored each other. CONCLUSIONS: Adipose mass, in and of itself, does not lead to IR. Severely obese individuals can be categorized as insulin resistant or non-insulin resistant, and the effect of GB depends upon this preoperative physiology; IR decreases in the former and beta-cell sensitivity increases in the latter. Metabolic characterization of patients is imperative in order to determine preoperative risk of obesity and assess outcomes following GB.
Back to 2006 Program and Abstracts